Active, Not Recruiting
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature
NCT03061539
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- University College London Hospital London, United Kingdom